• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在兔血栓形成模型中对铟 - 111标记的抑制性重组组织型纤溶酶原激活剂进行快速定位。

Rapid localization of indium-111-labeled inhibited recombinant tissue plasminogen activator in a rabbit thrombosis model.

作者信息

Butler S P, Kader K L, Owen J, Wang T S, Fawwaz R A, Alderson P O

机构信息

Department of Radiology, Columbia-Presbyterian Medical Center, New York, New York 10032.

出版信息

J Nucl Med. 1991 Mar;32(3):461-7.

PMID:1900886
Abstract

The thrombus localizing properties of indium-111-recombinant tissue plasminogen activator (111In-rt-PA) have been investigated in an effort to achieve prompt and accurate detection of thrombi. Unlike previous studies with rt-PA, the active plasminogen catalytic site was permanently inhibited with peptides of chloromethyl ketone so that the radiotracer binds to fibrin without causing fibrinolysis. Thrombi were created in the external jugular vein of 14 male New Zealand white rabbits followed by injection of 111In-rt-PA. The agent cleared rapidly in vivo with a half-time of 4.6 min. The thrombus: blood ratio in nonheparinized rabbits (n = 7) was 6.39 +/- 0.86. The ratio in heparinized rabbits (n = 4) was 3.11 +/- 0.23. Thrombi were clearly visible in the planar images of both groups 1 hr postinjection. The combination of rapid thrombus localization and positive images, especially in the presence of anticoagulation, suggests that further work is warranted with rt-PA thrombus imaging.

摘要

为了实现对血栓的快速准确检测,人们对铟 - 111重组组织型纤溶酶原激活剂(¹¹¹In - rt - PA)的血栓定位特性进行了研究。与以往对rt - PA的研究不同,活性纤溶酶原催化位点被氯甲基酮肽永久抑制,这样放射性示踪剂就能与纤维蛋白结合而不引起纤维蛋白溶解。在14只雄性新西兰白兔的颈外静脉中形成血栓,随后注射¹¹¹In - rt - PA。该制剂在体内清除迅速,半衰期为4.6分钟。未用肝素处理的兔子(n = 7)的血栓与血液比值为6.39±0.86。用肝素处理的兔子(n = 4)的比值为3.11±0.23。注射后1小时,两组的平面图像中血栓均清晰可见。快速的血栓定位和阳性图像的结合,尤其是在存在抗凝的情况下,表明rt - PA血栓成像值得进一步研究。

相似文献

1
Rapid localization of indium-111-labeled inhibited recombinant tissue plasminogen activator in a rabbit thrombosis model.在兔血栓形成模型中对铟 - 111标记的抑制性重组组织型纤溶酶原激活剂进行快速定位。
J Nucl Med. 1991 Mar;32(3):461-7.
2
Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi.用于血栓成像的铟-111标记重组组织型纤溶酶原激活剂的特性研究
Eur J Nucl Med. 1987;13(9):467-73. doi: 10.1007/BF00281862.
3
Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).大剂量组织型纤溶酶原激活剂及血浆半衰期延长的杂交纤溶酶原激活剂(K2tu-PA:CGP 42935)的溶栓和出血作用
Thromb Haemost. 1993 Aug 2;70(2):294-300.
4
In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats.锝-99m标记的重组组织型纤溶酶原激活剂在对照大鼠和有血栓大鼠体内的分布
Ann Nucl Med. 1992 Aug;6(3):177-84. doi: 10.1007/BF03178310.
5
Imaging of thrombi with tissue-type plasminogen activator rendered enzymatically inactive and conjugated to a residualizing label.
Circulation. 1992 Jan;85(1):288-97. doi: 10.1161/01.cir.85.1.288.
6
In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits.
Ann Nucl Med. 1994 Aug;8(3):193-9. doi: 10.1007/BF03164997.
7
Scintigraphic visualization of pulmonary thrombi with 123I-YPACK-TNK-tPA.使用123I-YPACK-TNK-tPA对肺血栓进行闪烁显像。
Coron Artery Dis. 1995 Sep;6(9):715-21.
8
Thrombolysis with an Escherichia coli-produced recombinant plasminogen activator (BM 06.022) in the rabbit model of jugular vein thrombosis.在兔颈静脉血栓形成模型中使用大肠杆菌产生的重组纤溶酶原激活剂(BM 06.022)进行溶栓治疗。
Thromb Haemost. 1991 May 6;65(5):560-4.
9
Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.组织型纤溶酶原激活剂(t-PA)、单链尿激酶型纤溶酶原激活剂(scu-PA)和尿激酶序贯输注对兔颈静脉血栓形成模型溶栓的协同作用。
Thromb Haemost. 1987 Oct 28;58(3):943-6.
10
Technetium-99m-modified recombinant tissue plasminogen activator to detect deep venous thrombosis.锝-99m标记的重组组织型纤溶酶原激活剂用于检测深静脉血栓形成。
J Nucl Med. 1996 May;37(5):744-8.

引用本文的文献

1
D-dimers increase in acute ischemic stroke patients with the large artery occlusion, but do not depend on the time of artery recanalization.D-二聚体在大动脉闭塞的急性缺血性脑卒中患者中增加,但不依赖于动脉再通时间。
J Thromb Thrombolysis. 2010 May;29(4):477-82. doi: 10.1007/s11239-009-0372-9.
2
Rationale for the rational development of new cardiac imaging agents.新型心脏成像剂合理研发的基本原理。
Ann Nucl Med. 1993 Nov;7(4):207-14. doi: 10.1007/BF03164700.
3
In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats.
锝-99m标记的重组组织型纤溶酶原激活剂在对照大鼠和有血栓大鼠体内的分布
Ann Nucl Med. 1992 Aug;6(3):177-84. doi: 10.1007/BF03178310.